Pulmonary fibrosis,Herbal medicine,Pharmacological agents,Bleomycin,paraquat," /> Pulmonary fibrosis,Herbal medicine,Pharmacological agents,Bleomycin,paraquat,"/>
| 1 Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K, Yamamoto M, Hizawa N.Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.
2 Naghani EE, Javadi I, Rashidinooshabadi M, Goudarzi M, Houshmand GR.Protective effects of hydroalcoholic extract of
3 Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D.Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
4 Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR.Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
5 Lynch JP 3rd, Huynh RH, Fishbein MC, Saggar R, Belperio JA, Weigt SS. Idiopathic pulmonary fibrosis: epidemiology, clinical features, prognosis, and management.
6 Javadi I, Rashidi Nooshabadi M, Goudarzi M, Roudbari R.Protective effects of celery (
7 Bahrami-Karkevandi M, Moshtaghian SJ, Mahzoni P, Adibi S, Kazemi S.The effects of hydroalcoholic extract of
8 Gross TJ, Hunninghake GW.Idiopathic pulmonary fibrosis.
9 Tang L, Jiang T, Han X, Chen D.Effect of tranilast on bleomycin-induced pulmonary fibrosis in a rat model.
10 Ertekin A, Deger Y, Mert H, Mert N, Yur F, Dede S, Demir H.Investigation of the effects of alpha-tocopherol on the levels of Fe, Cu, Zn, Mn, and carbonic anhydrase in rats with bleomycin-induced pulmonary fibrosis.
11 Kakugawa T, Mukae H, Hishikawa Y, Ishii H, Sakamoto N, Ishimatsu Y, Fujii T, Koji T, Kohno S.Localization of HSP47 mRNA in murine bleomycin-induced pulmonary fibrosis.
12 American Thoracic Society; European Respiratory Society.American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
13 Hemmati AA, Rezaie A, Darabpour P.Preventive effects of pomegranate seed extract on bleomycin-induced pulmonary fibrosis in rat.
14 Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.
15 Katzenstein AL, Myers JL.Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.
16 Kuhn C 3rd, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis.
17 Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis.
18 Hemmati AA, Hicks R.Increased myofibroblast contractile sensitivity in paraquat pretreated rat lung tissue.
19 Moeller A, Ask K, Warburton D, Gauldie J, Kolb M.The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
20 Martin GE, Ask K, Gilpin SE, Kolb M, Gauldie J.The transforming growth factor-beta (TGF-β) family and pulmonary fibrosis.
21 Safaeian L, Dehkordi AJ, Afsharmoghaddam N, Sarahroodi S.The effects of Silymarin in bleomycin-induced pulmonary fibrosis in mice.
22 Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F, Bastos ML, Carvalho F.Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment.
23 Hemmati A, Nazari Z, Motlagh M, Goldasteh S.The role of sodium cromolyn in treatment of paraquat-induced pulmonary fibrosis in rat.
24 Mojiri-Forushani H, Hemmati AA, Khodadadi A, Assarehzadegan M, Rashno M.Protective effect of valsartan on beleomycin-induced fibrosis.
25 Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
26 Jiang C, Huang H, Liu J, Wang Y, Lu Z, Xu Z.Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials.
27 J a v a d - M o u s a v i S A, H e m m a t i A A, M e h r z a d i S, Hosseinzadeh A, Houshmand G, Rashidi Nooshabadi MR, Mehrabani M, Goudarzi M. Protective effect of
28 Chilakapati SR, Serasanambati M, Manikonda PK, Chilakapati DR, Watson RR.Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice.
29 Li L, Li D, Xu L, Zhao P, Deng Z, Mo X, Li P, Qi L, Li J, Gao J.Total extract of Yupingfeng attenuates bleomycininduced pulmonary fibrosis in rats.
30 Ghorashi M, Rezaee MA, Rezaie MJ, Mohammadi M, Jalili A, Rahmani MR.The attenuating effect of aqueous extract of licorice on bleomycin-induced pulmonary fibrosis in mice.
31 Hemmati A, Arzi A, Adinehv A, Mostofi N, Mozaffari A, Jalali A.Yarrow (
32 Hemmati AA, Aghel N, Nazari Z, Mohammadian B, Hasanvand N.Protective effect of grape seed extract against the fibrogenic effect of bleomycin in rat lung.
33 Hemmati AA, Nazari Z, Samei M.A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats.
34 Asghari MH, Hobbenaghi R, Nazarizadeh A, Mikaili P.Hydro-alcoholic extract of
35 Kar S, Konsam S, Hore G, Mitra S, Biswas S, Sinha A, Jana NR, Banerjee ER.Therapeutic use of fisetin, curcumin, and mesoporous carbaon nanoparticle loaded fisetin in bleomycin-induced idiopathic pulmonary fibrosis.
36 Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA.Effect of glycosides-based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL- 1β.
37 Zhan H, Huang F, Ma W, Zhao Z, Zhang H, Zhang C.Protective effect of ginsenoside Rg1 on bleomycin-induced pulmonary fibrosis in rats: involvement of caveolin-1 and TGF-β1 signal pathway.
38 Malayeri AR, Hemmati AA, Arzi A, Rezaie A, Ghafurian- Boroojerdnia M, Khalili HR.A comparison of the effects of quercetin hydrate with those of vitamin E on the levels of IL-13, PDGF, TNF-α, and INF-γ in bleomycin-induced pulmonary fibrosis in rats.
41 Nikbakht J, Hemmati AA, Arzi A, Mansouri MT, Rezaie A, Ghafourian M.Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats.
42 You H, Wei L, Sun WL, Wang L, Yang ZL, Liu Y, Zheng K, Wang Y, Zhang WJ.The green tea extract epigallocatechin- 3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats.
43 Larki-Harchegani A, Hemmati AA, Arzi A, Ghafurian- Boroojerdnia M, Shabib S, Zadkarami MR, Esmaeilzadeh S.Evaluation of the effects of caffeic acid phenethyl ester on prostaglandin E2 and two key cytokines involved in bleomycin-induced pulmonary fibrosis.
44 Larki A, Hemmati AA, Arzi A, Borujerdnia MG, Esmaeilzadeh S, Zad Karami MR.Regulatory effect of caffeic acid phenethyl ester on type I collagen and interferon-gamma in bleomycin-induced pulmonary fibrosis in rat.
45 Zaeemzadeh N, Hemmati A, Arzi A, Jalali M, Rashidi I.Protective effect of caffeic acid phenethyl ester (CAPE) on amiodarone-induced pulmonary fibrosisin rat.
46 Hemmati AA, Zaeemzadeh N, Arzi A, Jalali MT, Rashidi I.Impact of cafeic acid phenethyl ester (CAPE) on amiodarone-induced pulmonary fibrosis in rat.
47 Akgedik R, Akgedik S, Karamanli H, Uysal S, Bozkurt B, Ozol D, Armutcu F, Yıldırım Z.Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats.
48 Hemmati AA, Kazemi M, Pashmforoosh M, Rajabi- Vardanjani H, Shabib S, Nili-Ahmadabadi A, Larki A.Sildenafil, a selective inhibitor of type 5 phosphodiesterase, attenuates bleomycin-induced lung fibrosis in rat.Biological Forum; 2015; 7(2): 1067-1071.
49 Khodayar MJ, Kiani M, Hemmati AA, Rezaie A, Zerafatfard MR, Rashidi Nooshabadi MR, Goudarzi M.The preventive effect of atorvastatin on paraquat-induced pulmonary fibrosis in the rats.
50 Mikaili P, Hemmati AA, Khodayar MJ, Ghafurian M, Rashidi I.The protective effect of penicillamine against bleomycine-induced pulmonary fibrosis in rats.
51 Mikaili P, Hemmati AA, Khodayar MJ, Ghafurian M, Rashidi I.Evaluation of the effects of nicotinamide on the bleomycin-induced pulmonary fibrosis in rat.
52 Ermis H, Parlakpinar H, Gulbas G, Vardi N, Polat A, Cetin A, Kilic T, Aytemur ZA.Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats.
53 Kalayarasan S, Sriram N, Soumyakrishnan S, Sudhandiran G.Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2.
54 Hemmati AA, Mikaili P, Khodayar MJ, Ghafurian M, Rashidi I.The protective effect of cetirizine against bleomycin-induced pulmonary fibrosis in rats.
55 Hemmati AA, Nazari Z, Rashidi I, Kazemi Z.Protective effect of ketotifen on bleomycin-induced pulmonary fibrosis in rat.
56 Guo F, Sun YB, Su L, Li S, Liu ZF, Li J, Hu XT, Li J.Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
57 Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD.Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor.
58 Ghazi-Khansari M, Mohammadi-Karakani A, Sotoudeh M, Mokhtary P, Pour-Esmaeil E, Maghsoud S.Antifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats.
59 Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S.Reduction of bleomycin-induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
60 Marut W, Kavian N, Servettaz A, Hua-Huy T, Nicco C, Chéreau C, Weill B, Dinh-Xuan AT, Batteux F.Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
61 Amirshahrokhi K.Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in mice.
62 Liu B, Cao B, Zhang D, Xiao N, Chen H, Li GQ, Peng SC, Wei LQ.Salvianolic acid B protects against paraquatinduced pulmonary injury by mediating Nrf2/Nox4 redox balance and TGF-β1/Smad3 signaling.
63 Aoki Y, Maeno T, Aoyagi K, Ueno M, Aoki F, Aoki N, Nakagawa J, Sando Y, Shimizu Y, Suga T, Arai M, Kurabayashi M.Pioglitazone, a peroxisome proliferatoractivated receptor γ ligand, suppresses bleomycin-induced acute lung injury and fibrosis.
|||Cai-lian Fana, Wan-jun Caib, Meng-nan Ye, Miao Chen, Yi Dai. Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro. Journal of Integrative Medicine, 2022, 20(4): 365-375.|
|||Tareq A. Wani, Zahoor A. Kaloo, Nisar A. Dangroo. Aconitum heterophyllum Wall. ex Royle: A critically endangered medicinal herb with rich potential for use in medicine. Journal of Integrative Medicine, 2022, 20(2): 104-113.|
|||Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.|
|||Rakhi Chakraborty, Swarnendu Roy. Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. Journal of Integrative Medicine, 2021, 19(6): 478-492.|
|||Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466.|
|||Ruo-lan Li, Qing Zhang, Jia Liu, Li-ying He, Qin-wan Huang, Wei Peng, Chun-jie Wu. Processing methods and mechanisms for alkaloid-rich Chinese herbal medicines: A review. Journal of Integrative Medicine, 2021, 19(2): 89-103.|
|||Jie Wu, Shu-wei Duan, Hong-tao Yang, Yue-yi Deng, Wei Li, Ya-ni He, Zhao-hui Ni, Yong-li Zhan, Shan Lin, Zhi-yong Guo, Jun Zhu, Jing-ai Fang, Xu-sheng Liu, Li-hua Wang, Rong Wang, Nian-song Wang, Xiao-hong Cheng, Li-qun He, Ping Luo, Shi-ren Sun s, Ji-feng Sun, Ai-ping Yin, Geng-ru Jiang, Hong-yu Chen, Wen-hu Liu, Hong-li Lin, Meng Liang, Lu Ma, Ming Chen, Li-qun Song, Jian Chen, Qing Zhu, Chang-ying Xing, Yun Li, Ji-ning Gao, Rong-shan Li, Ying Li, Hao Zhang, Ying Lu, Qiao-ling Zhou, Jun-zhou Fu, Qiang He, Guang-yan Cai, Xiang-mei Chen. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial. Journal of Integrative Medicine, 2021, 19(2): 111-119.|
|||Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190.|
|||Ming-sheng Lyu, De-ying Li, Shao-zhong Zhou, Cheng-jun Ban, Jun Yan. Adult-onset Still's disease successfully treated with Chinese herbal medicine: A case report with 15-month follow-up. Journal of Integrative Medicine, 2020, 18(6): 530-534.|
|||Qing-lan Wang, Yan-yan Tao, Hong-dong Xie, Cheng-hai Liu, Ping Liu. Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis. Journal of Integrative Medicine, 2020, 18(6): 505-513.|
|||Mu-yan Kong, Le-yan Li, Yan-mei Lou, Hong-yu Chi, Jin-jun Wu. Chinese herbal medicines for prevention and treatment of colorectal cancer: from molecular mechanisms to potential clinical applications. Journal of Integrative Medicine, 2020, 18(5): 369-384.|
|||. External application of two unrestricted herbal medicines to treat costochondritis in a young collegiate athlete: A case report. Journal of Integrative Medicine, 2020, 18(5): 450-454.|
|||Arthur Yin Fan, Sherman Gu, Sarah Faggert Alemi, Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(5): 385-394.|
|||Shuai Yan, Yin-zi Yue, Ming-ming Sun, Ben-sheng Wu, Xiao-peng Wang. Suppressive effect of Aurantii Fructus Immaturus and Atractylodis Macrocephalae Rhizoma on glutamic acid-induced autophagy of interstitial cells of Cajal. Journal of Integrative Medicine, 2020, 18(4): 334-343.|
|||Bin Lan, Jin-wen Ge, Shao-wu Cheng, Xi-long Zheng, Jun Liao, Chao He, Zheng-qing Rao, Guo-zuo Wang. Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. Journal of Integrative Medicine, 2020, 18(4): 344-350.|